(redirected from Alzheimer's dementia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
References in periodicals archive ?
Rockwood and his colleagues included participants without dementia or with Alzheimer's dementia at their last clinical assessment.
For the first time, scientists have attempted to account for numbers of people with biomarkers or other evidence of possible preclinical Alzheimer's disease, but who do not have impairment or Alzheimer's dementia.
By 2060, about 15 million American citizens will have Alzheimer's dementia or mild cognitive impairment, according to a new study.
The Chicago-based association estimates that 5.5 million Americans now have Alzheimer's dementia, up from 5.4 million last year.
Significant increases in ADNP RNA levels were observed in patients ranging from mild cognitive impairment to Alzheimer's dementia.
Researchers found that specific NPS are associated with a shorter time between mild Alzheimer's dementia and severe dementia or death.
The drug, commonly used to treat epilepsy, calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI), a clinically recognized condition in which memory impairment is greater than expected for a person's age and which greatly increases risk for Alzheimer's dementia, according to the study conducted by researchers at Johns Hopkins University and published this week in NeuroImage: Clinical.
Participants who tested positive for amyloid on florbetapir (Amyvid) PET scan at baseline were five times more likely to convert to Alzheimer's dementia within 3 years than were amyloid-negative subjects, data from the large, multisite imaging registry showed.
Alzheimer's dementia is the most ordinary type of dementia and encoding of unambiguous declarative information is the chief memory shortfall in it.
This alliance moves us one step closer to achieving our goal of making Alzheimer's dementia preventable by 2025."
An International Classification of Disease10th Edition (ICD-10) criterion for the diagnosis of Alzheimer's Dementia was used in this study and patients were selected through consecutive sampling.
IntelliCell Biosciences and GAIN are developing joint protocols with initial efforts focusing on the assessment and treatment of children and adults with Autism, Alzheimer's Dementia, and returning soldiers with blast induced traumatic brain injury.

Full browser ?